What is the enterprise number of DIFARMEX?

The enterprise number of DIFARMEX is BE0453209833.

What is the address of DIFARMEX?

The registered office of DIFARMEX is located at Koosterstraat 51, 3570 Alken.

When was DIFARMEX founded?

DIFARMEX was founded on 5 August 1994.

Does DIFARMEX have a website?

No website is currently known for DIFARMEX.

How much profit did DIFARMEX make in 2025?

DIFARMEX recorded a loss after taxes of € 4,091 in financial year 2025.

What is the revenue of DIFARMEX?

As a small company, DIFARMEX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 3,879.

Where can I find the annual accounts of DIFARMEX?

DIFARMEX files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.

Who are the directors of DIFARMEX?

According to the 2025 annual accounts, the directors of DIFARMEX are: Stephan Tans, Maria Adams.

DIFARMEX (Public Limited) - Alken (3570) - BE0453209833

Financials

Financial year 2025

Worth noting

Little cash and receivables against the short-term debts.

Gross margin

€ 3,879

▼ 77% vs 2024

Profit

Caution

€ -4,091

▼ 147% vs 2024

Debts

Low

€ 89,186

▼ 5% vs 2024

DIFARMEX from Alken, company number BE0453209833, closed financial year 2025 with a result of € -4,091 after tax. For that financial year DIFARMEX recorded a gross margin of € 3,879 and equity of € 200,895. Compared with financial year 2024, the result moved from € 8,660 to € -4,091. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What happened at DIFARMEX?

What happened at DIFARMEX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2026 New annual accounts for financial year 2025: loss of € 4,091 (▼ 147% vs 2024). Source: NBB ↗
Apr 20, 1999 New establishment in Alken. KBO
Aug 5, 1994 Start of the company according to the CBE. KBO

In short

From € 5,989 profit in 2021 to € 4,091 loss in 2025.

Best year ever: 2024, with € 8,660 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DIFARMEX? We notify you, reason included.

Follow DIFARMEX

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New

Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Stephan Tans

Maria Adams

DIFARMEX

GAMMA PROJECTS

Behind DIFARMEX are Stephan Tans and Maria Adams. The same people are also behind GAMMA PROJECTS.

See the full network in the app

Directors

According to the 2025 annual accounts

Stephan Tans

Managing director

Also active at: GAMMA PROJECTS

Maria Adams

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Koosterstraat 51

3570 Alken

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0453.209.833
VAT number: BE 0453.209.833
Registered office: Koosterstraat 51, 3570 Alken
Names & denominations: DIFARMEX
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 5 August 1994
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗